Creating equal access to quality diabetes care
We are developing an insulin pen for all
Photo: stock.adobe.com
“I like this device because the reservoir lasts for more than one day. It’s easier than using syringes daily.”
— Test person during a usability study done in collaboration with Médecins Sans Frontières
Compared to syringe and vials, pens are known to help people be able to follow their insulin regimens, and to reduce healthcare utilization costs.
-
537 million adults live with diabetes. The condition is spiralling out of control – in terms of numbers of people living with diabetes, lives claimed and disabilities caused.
-
More than 60 million people with type 2 diabetes require insulin to best manage their condition.
-
Today, 13 million people living with diabetes don’t have access to insulin pens for their daily injections. Instead, they use a disposable syringe.
We combine new and existing technology
We keep the cost of research and development at a minimum because we believe
that every person with diabetes should be able to take their insulin in an easy and safe way.
Awards & recognitions
-
![]()
GO-Pen was recognised for being the only insulin pen where people with diabetes can buy insulin in vials and fill their own reservoirs for use with an insulin pen. See press release
-
![]()
In the diabetes devices category, GO-Pen was recognised for its vision is to make a difference for the millions of people living with diabetes who currently cannot afford modern devices. See news release
-
![]()
GO-Pen was a finalist in the category Startup in the Sealand Region. See more.
-
![]()
GO-Pen was a finalist in the category Social Entrepreneurship - Future Impact. See list.
-
![]()
See interview (in Danish)
